Sign In
Buy OVID
$2.44
-0.0100 (-0.408%)
At Close: Jul 17, 2026
歐盟委員會同意武田無需履行從夏爾後續化合物SHP647撤資的承諾
12:00am, Monday, 01'st Jun 2020
(美國商業資訊)-- 武田藥品工業株式會社(Takeda Pharmaceutical Company Limited) (TOKYO:4502) (NYSE:TAK)（「武田」）今天宣佈，歐盟委員會(“EC”)於5月28日解除了武�
En el día de hoy, Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) anunció que los resultados del ensayo Pevonedistat-2001 de fase II se pres
Xconomy: Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs
02:30am, Saturday, 30'th May 2020
Forma Therapeutics has developed a pipeline of small molecules aimed at rare blood disorders and cancers, but it aims to advance two---investigational
La Commissione europea svincola Takeda dall’obbligo di cessione del composto in corso di sviluppo SHP647 di Shire
12:00am, Friday, 29'th May 2020
Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) ha annunciato oggi che in data 28 maggio la Commissione europea (la “CE”) ha
20 stocks working on COVID-19 cures and treatments | Finder
05:51am, Thursday, 28'th May 2020
Could one of these biotech stocks be the one?
Treatment Of COVID-19: Operation Warp Speed, "Engage." - ValueWalk
04:34pm, Wednesday, 27'th May 2020
There are 224 candidates in development for the treatment of COVID-19 currently. Given the breadth of the product offerings by the “big boys”
6 Stock Charts to Watch: ALT, CAR, MGM, JETS, OVID, VLO
12:00am, Wednesday, 27'th May 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Ballard Power Systems Inc, MGM Resorts International, Darden Restaurants Inc. Read Harry Boxer's latest article on Investing.com
Xconomy: COVID-19 Sparks New Opportunities for Digital Health Companies
11:00am, Tuesday, 26'th May 2020
Clinicians and regulators are rethinking how healthcare is provided amid precautions prompted by COVID-19. In-person physician visits don’t fit within the
美国FDA核准武田ALUNBRIG® (brigatinib)用作一种罕见严重类型肺癌患者的一线治疗选择
12:00am, Monday, 25'th May 2020
(美国商业资讯)--武田药品工业株式会社(Takeda Pharmaceutical Company Limited) (TSE:4502/NYSE:TAK)今天宣布，美国食品药品管理局(FDA)核准ALUNBRIG (brigatinib)用于经一项
